Future direction for research in pulmonary embolism.

Back

ESC Premium Access

Future direction for research in pulmonary embolism.

Session: Optimizing the treatment of pulmonary embolism

Topic: Acute pulmonary embolism

Speaker: Professor H. Buller (Amsterdam, NL)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Harry Buller

Academic Medical Centre, Amsterdam (Netherlands (The))

5 presentations

0 follower

4 more presentations in this session

State of the art in the management of pulmonary embolism.

Speaker: Professor C. Becattini (Perugia, IT)

Access

Slides

Video

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation

Speaker: Doctor E. Klok (Leiden, NL)

National trends in inferior vena cava filter placement in the United States from 2005 to 2013

Speaker: Professor D. Brown (Los Angeles, US)

Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?

Speaker: Doctor E. Weeda (Storrs, US)

Access the full session

Optimizing the treatment of pulmonary embolism

Speakers: Professor H. Buller, Professor C. Becattini, Doctor E. Klok, Professor D. Brown, Doctor E. Weeda

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

Future direction for research in pulmonary embolism.

About the speaker

Professor Harry Buller

4 more presentations in this session

State of the art in the management of pulmonary embolism.

Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation

National trends in inferior vena cava filter placement in the United States from 2005 to 2013

Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?

Access the full session

Optimizing the treatment of pulmonary embolism

About the event

ESC Congress 2016

ESC 365 is supported by